Harvard Bioscience, Inc. (HBIO) - Multiplikator forward rega marang pendapatan

Harvard Bioscience Inc. (HBIO) - logo korporat

Harvard Bioscience is implementing eco-friendly production standards, reducing its carbon footprint and costs. Stable demand from laboratories ensures resilience against crises. GURU.Markets analytics provide a forward-looking P/S valuation, where 0.50 serves as the current parameter value. Global diversification of assembly across the US and EU minimizes geopolitical risks, supporting the operational stability of the business.

HBIO harvardbioscience.com: Multiplikator forward rega marang pendapatan ing interval 04.07.2022 - 13.11.2026

harvardbioscience.com - rincian analitis lan metrik utama (HBIO)

Analisis umum perusahaan:HBIO (Harvard Bioscience)
Produk asli Harvard Bioscience Inc.

This indicator determines the market value of a unit of expected revenue, allowing investors to assess future business growth rates between official reports. When analyzing the forward price-to-sales ratio, one must consider the dependence of Harvard Bioscience (HBIO) on the volume of government science funding in the US and Europe, as a reduction in grants directly diminishes the fundamental attractiveness of expected sales.

Analisis perusahaan pesaing

Rasio rega marang prakiraan pendapatan Intuitive ISRG|Rega forward marang dodolan DHR|BDX: Multiplikator forward rega marang pendapatan|STE - Multiplikator Forward P/S|West Pharmaceutical Services (WST) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan baxter.com|MASI (Masimo) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Stevanato Group SpA STVN|Rasio rega marang prakiraan pendapatan Teleflex Inc (TFX)|Merit Medical Corp - Kapitalisasi marang prakiraan pendapatan|Envista Holdings - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ICUI (icumed.com)|XRAY - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake LeMaitre Vascular Inc LMAT|ATRC: Multiplikator Forward P/S|STAAR Surgical Co - Rega forward marang dodolan|NAGE (ChromaDex Corporation) - Multiplikator Forward P/S|Multiplikator Forward P/S zimvie.com|Rasio rega marang prakiraan pendapatan AngioDynamics (ANGO)|CERS (Cerus Corp.) - Rega forward marang dodolan|Alpha Teknova Inc - Multiplikator forward rega marang pendapatan|Monogram Orthopedics Inc. - Rasio rega marang prakiraan pendapatan|Sharps Tech - Multiplikator Forward P/S|INFU - Multiplikator Forward P/S|Utah Medical Products, Inc. (UTMD) - Rasio rega marang prakiraan pendapatan|KORU Medical - Rega forward marang dodolan|NYXH (Nyxoah, S.A.) - Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan MBOT (Microbot Medical, Inc)|Multiplikator forward rega marang pendapatan PDEX (Pro-Dex, Inc.)|ZTEK (zentek.com) - Rega forward marang dodolan|Multiplikator Forward P/S ELUT (Elutia)|Milestone Scientific Inc - Rasio rega marang prakiraan pendapatan|NEXGEL, Inc - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Retractable Technologies RVP|Femasys Inc. (FEMY) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Meihua Medical Technologies Co., Ltd. (MHUA)|Rasio rega marang prakiraan pendapatan Predictive Oncology Inc|Callan JMB Corp (CJMB) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S ATRI|Multiplikator forward rega marang pendapatan NeuroMetrix Corporation NURO